• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:QTZM)

1.400 +0.010 (+0.72%)
Streaming Delayed Price Updated: 11:38 AM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,004
Open 1.400
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 1.390
Today's Range 1.330 - 1.400
52wk Range 0.0025 - 1.910
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Quantumzyme Announces Publication of Patents Supporting Sustainable Pharmaceutical Growth & Innovation
October 31, 2025
Via TheNewswire.com
Topics Intellectual Property
Quantumzyme Announces Publication of Patents Supporting Sustainable Pharmaceutical Growth & Innovation
October 31, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property

Performance

YTD
+197.9%
+197.9%
1 Month
+2700.0%
+2700.0%
3 Month
+774.5%
+774.5%
6 Month
+11969.0%
+11969.0%
1 Year
+197.9%
+197.9%

More News

Read More
Quantumzyme Corp. Participated in Enzyme Engineering XXVIII Conference in Denmark
October 28, 2025
Via NewMediaWire
Topics Artificial Intelligence Intellectual Property
Quantumzyme Corp. Participated in Enzyme Engineering XXVIII Conference in Denmark
October 28, 2025
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
Quantumzyme Corp. Announces USPTO Publication of Breakthrough Ibuprofen Patent
September 24, 2025
Via NewMediaWire
Topics Intellectual Property
Quantumzyme Corp. Announces USPTO Publication of Breakthrough Ibuprofen Patent
September 24, 2025
Via TheNewswire.com
Topics Intellectual Property
Quantumzyme Announces Removal of OTC Markets Caveat Emptor Designation
July 24, 2025
Via TheNewswire.com
Quantumzyme Announces Removal of OTC Markets Caveat Emptor Designation
July 24, 2025
Via NewMediaWire
Quantumzyme Responds to OTC Markets Caveat Emptor Designation and Denounces Unauthorized Promotion Activity
April 30, 2025
Via NewMediaWire
Quantumzyme Responds to OTC Markets Caveat Emptor Designation and Denounces Unauthorized Promotion Activity
April 30, 2025
Via TheNewswire.com
Quantumzyme Highlights Benefits and Commercialization Opportunities of Pending Breakthrough Green Chemistry Patent
April 28, 2025
Via NewMediaWire
Topics Artificial Intelligence Intellectual Property
Quantumzyme Highlights Benefits and Commercialization Opportunities of Pending Breakthrough Green Chemistry Patent
April 28, 2025
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
Quantumzyme Anticipates Publication of Transformative Patent for Enzymatic Ibuprofen Manufacturing
April 23, 2025
Via NewMediaWire
Topics Intellectual Property
Quantumzyme Anticipates Publication of Transformative Patent for Enzymatic Ibuprofen Manufacturing
April 23, 2025
Via TheNewswire.com
Topics Intellectual Property
Quantumzyme Highlights Enzyme Engineering Platform and Ongoing Work in Sustainable Ibuprofen Synthesis
April 16, 2025
Via NewMediaWire
Quantumzyme: Advancing Enzymatic Innovation for a Sustainable Industrial Future
April 11, 2025
Via NewMediaWire
Topics Artificial Intelligence
Quantumzyme Introduces Manu Bharath Khareedhi as Independent Director, Looks to Strengthen Strategic Growth and Innovation
April 08, 2025
Via NewMediaWire
Quantumzyme Introduces Manu Bharath Khareedhi as Independent Director, Looks to Strengthen Strategic Growth and Innovation
April 08, 2025
Via TheNewswire.com
Quantumzyme Signs MOU With Zummit Africa to Establish a Centre of Excellence in AI for Green Chemistry
April 04, 2025
Via TheNewswire.com
Topics Artificial Intelligence
Quantumzyme Signs MOU With Zummit Africa to Establish a Centre of Excellence in AI for Green Chemistry
April 04, 2025
Via NewMediaWire
Topics Artificial Intelligence
Quantumzyme to Become Fully Reporting SEC Issuer, Unlocking New Growth Potential
April 03, 2025
Via NewMediaWire
Topics Regulatory Compliance
Quantumzyme to Become Fully Reporting SEC Issuer, Unlocking New Growth Potential
April 03, 2025
Via TheNewswire.com
Topics Regulatory Compliance
Quantumzyme Highlights Breakthroughs in Enzymatic Catalysis at CCE 2025
April 01, 2025
Via TheNewswire.com
Topics Emissions
Quantumzyme Highlights Breakthroughs in Enzymatic Catalysis at CCE 2025
April 01, 2025
Via NewMediaWire
Topics Emissions
Quantumzyme Announces Vision to Lead the Future of Sustainable Industrial Biocatalysis
March 27, 2025
Via NewMediaWire
Topics Artificial Intelligence

Frequently Asked Questions

Is QTZM publicly traded?
Yes, QTZM is publicly traded.
What exchange does QTZM trade on?
QTZM trades on the OTC Traded
What is the ticker symbol for QTZM?
The ticker symbol for QTZM is QTZM on the OTC Traded
What is the current price of QTZM?
The current price of QTZM is 1.400
When was QTZM last traded?
The last trade of QTZM was at 11/03/25 11:38 AM ET
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap